Non-interventional Prospective Observational Survey to Describe EGb 761 (Tanakan) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive Disorders.

Trial Profile

Non-interventional Prospective Observational Survey to Describe EGb 761 (Tanakan) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive Disorders.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Jul 2015

At a glance

  • Drugs EGb 761 (Primary)
  • Indications Cognition disorders
  • Focus Therapeutic Use
  • Acronyms TAYPES
  • Sponsors Ipsen
  • Most Recent Events

    • 30 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 04 Mar 2015 Planned End Date changed from 1 May 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov record.
    • 04 Mar 2015 Planned primary completion date changed from 1 May 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top